Bosun Asset Management LLC bought a new stake in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 24,268 shares of the company's stock, valued at approximately $433,000. Bosun Asset Management LLC owned approximately 0.07% of Grail as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors have also recently made changes to their positions in GRAL. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in Grail during the 4th quarter valued at approximately $244,000. Moloney Securities Asset Management LLC bought a new position in shares of Grail during the fourth quarter valued at $559,000. Rhumbline Advisers purchased a new position in shares of Grail in the 4th quarter worth about $456,000. Wesbanco Bank Inc. bought a new position in Grail in the 4th quarter worth about $523,000. Finally, Slow Capital Inc. purchased a new stake in Grail during the 4th quarter valued at about $2,379,000.
Grail Stock Performance
GRAL opened at $32.16 on Wednesday. The company's 50-day simple moving average is $29.75 and its two-hundred day simple moving average is $25.34. Grail, Inc. has a 52-week low of $12.33 and a 52-week high of $63.99.
Grail (NASDAQ:GRAL - Get Free Report) last issued its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, beating analysts' consensus estimates of ($4.41) by $2.55. The company had revenue of $38.25 million for the quarter, compared to the consensus estimate of $35.33 million. On average, sell-side analysts predict that Grail, Inc. will post -15.15 earnings per share for the current fiscal year.
Insider Transactions at Grail
In other Grail news, CFO Aaron Freidin sold 41,150 shares of the stock in a transaction dated Friday, May 2nd. The stock was sold at an average price of $33.93, for a total value of $1,396,219.50. Following the transaction, the chief financial officer now owns 294,020 shares of the company's stock, valued at approximately $9,976,098.60. This represents a 12.28 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Robert P. Ragusa sold 7,625 shares of the firm's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $31.21, for a total value of $237,976.25. Following the completion of the transaction, the chief executive officer now directly owns 828,662 shares in the company, valued at $25,862,541.02. The trade was a 0.91 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 194,948 shares of company stock worth $6,583,130 in the last ninety days.
Analyst Upgrades and Downgrades
GRAL has been the topic of several analyst reports. Canaccord Genuity Group started coverage on shares of Grail in a research note on Monday, April 21st. They issued a "buy" rating and a $32.00 target price on the stock. Morgan Stanley upped their price objective on Grail from $16.00 to $20.00 and gave the company an "equal weight" rating in a research report on Tuesday, March 18th.
Check Out Our Latest Research Report on Grail
About Grail
(
Free Report)
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Recommended Stories
Want to see what other hedge funds are holding GRAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Grail, Inc. (NASDAQ:GRAL - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
